8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide
C37H39F2N7O7S — CID 166968354
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide
8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide (PubChem CID 166968354) has the molecular formula C37H39F2N7O7S and a molecular weight of 763.82 g/mol. Its IUPAC name is 8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide.
Molecular Properties
| Compound Name | 8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide |
|---|---|
| PubChem CID | 166968354 |
| Molecular Formula | C37H39F2N7O7S |
| Molecular Weight | 763.82 g/mol |
| Exact Mass | 763.26 |
| IUPAC Name | 8-(3,5-difluoro-2-pyridinyl)-15-methyl-4-(methylsulfonylmethyl)-14-oxo-N-[5-[[5-(2-oxo-2-pyrrolidin-1-ylethyl)-1,2-oxazol-3-yl]oxy]pentyl]-8,12,15-triazatetracyclo[8.6.1.02,7.013,17]heptadeca-1(16),2(7),3,5,10,13(17)-hexaene-5-carboxamide |
| SMILES | Cn1cc2c3c(c[nH]c3c1=O)CN(c1ncc(F)cc1F)c1cc(C(=O)NCCCCCOc3cc(CC(=O)N4CCCC4)on3)c(CS(C)(=O)=O)cc1-2 |
| InChI | InChI=1S/C37H39F2N7O7S/c1-44-20-28-27-12-22(21-54(2,50)51)26(16-30(27)46(35-29(39)13-24(38)18-42-35)19-23-17-41-34(33(23)28)37(44)49)36(48)40-8-4-3-7-11-52-31-14-25(53-43-31)15-32(47)45-9-5-6-10-45/h12-14,16-18,20,41H,3-11,15,19,21H2,1-2H3,(H,40,48) |
| InChIKey | PWJVYCFMEDEMRA-UHFFFAOYSA-N |
| XLogP | 4.54 |
| TPSA | 172.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 763.82 |
| LogP ≤ 5 | 4.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166968354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.